featured
SGLT2 Inhibition and Type 1 Diabetes
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Diabetes Care
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Sodium-Glucose Cotransporter 2 Inhibition and Glycemic Control in Type 1 Diabetes: Results of an 8-Week Open-Label Proof-of-Concept Trial
Diabetes Care 2014 May 01;37(5)1480-1483, BA Perkins, DZ Cherney, H Partridge, N Soleymanlou, H Tschirhart, B Zinman, NM Fagan, S Kaspers, HJ Woerle, UC Broedl, OE JohansenFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.